118 related articles for article (PubMed ID: 9455040)
1. [Estimation of 123I-metaiodobenzylguanidine lung uptake in heart and lung diseases--with reference to lung uptake ratio and decrease of lung uptake].
Fujii T; Tanaka M; Yazaki Y; Kitabayashi H; Koizumi T; Sekiguchi M; Gomi T; Yano K; Itoh A
Kaku Igaku; 1997 Nov; 34(11):1005-11. PubMed ID: 9455040
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification assessed by combined lung and heart iodine-123 metaiodobenzylguanidine uptake in patients with idiopathic dilated cardiomyopathy.
Kamiyoshi Y; Yazaki Y; Urushibata K; Koizumu T; Kasai H; Izawa A; Kinoshita O; Hongo M; Ikeda U
Am J Cardiol; 2008 May; 101(10):1482-6. PubMed ID: 18471462
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of most appropriate background subtraction method for quantification of 123I-metaiodobenzylguanidine (MIBG) myocardial uptake by comparing with plasma ANP and BNP].
Yahara Y; Nomura Y; Okamoto S; Saitou K; Okamoto R; Makino K; Aoki S; Takeda K
Kaku Igaku; 2000 May; 37(3):217-25. PubMed ID: 10860352
[TBL] [Abstract][Full Text] [Related]
4. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in high-altitude pulmonary oedema.
Urushihata K; Koizumi T; Hanaoka M; Fujimoto K; Kubo K; Kobayashi T; Fujii T
Respirology; 2008 Nov; 13(6):897-902. PubMed ID: 18657059
[TBL] [Abstract][Full Text] [Related]
5. Impairment of Iodine-123-Metaiodobenzylguanidine (
Higo K; Kubota K; Miyanaga S; Miyata M; Nakajo M; Jinguji M; Ohishi M
Int Heart J; 2018 Jan; 59(1):112-119. PubMed ID: 29332912
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of 123I-MIBG after acute myocardial infarction and reperfusion therapy.
Bengel FM; Barthel P; Matsunari I; Schmidt G; Schwaiger M
J Nucl Med; 1999 Jun; 40(6):904-10. PubMed ID: 10452304
[TBL] [Abstract][Full Text] [Related]
7. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure].
Narita M; Kurihara T; Murano K; Usami M; Honda M
Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231
[TBL] [Abstract][Full Text] [Related]
8. Prolonged lung retention of iodine-123-MIBG in diabetic patients.
Unlü M; Inanir S
J Nucl Med; 1998 Jan; 39(1):116-8. PubMed ID: 9443749
[TBL] [Abstract][Full Text] [Related]
9. ¹²³I-MIBG heart-to-mediastinum ratio is influenced by high-energy photon penetration of collimator septa from liver and lung activity.
Verschure DO; de Wit TC; Bongers V; Hagen PJ; Sonneck-Koenne C; D'Aron J; Huber K; van Eck-Smit BL; Knoll P; Somsen GA; Mirzaei S; Verberne HJ
Nucl Med Commun; 2015 Mar; 36(3):279-85. PubMed ID: 25415845
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of lung iodine-123 metaiodobenzylguanidine uptake assessment in Parkinson's and heart diseases.
Nakae I; Hayashi H; Mitsunami K; Horie M
Ann Nucl Med; 2013 Oct; 27(8):737-47. PubMed ID: 23728513
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of lung uptake of iodine-123 metaiodobenzylguanidine (MIBG), a myocardial sympathetic nerve imaging agent, in patients with chronic heart failure.
Mu X; Hasegawa S; Yoshioka J; Maruyama A; Maruyama K; Paul AK; Yamaguchi H; Morozumi T; Hashimoto K; Kusuoka H; Nishimura T
Ann Nucl Med; 2001 Oct; 15(5):411-6. PubMed ID: 11758945
[TBL] [Abstract][Full Text] [Related]
12. Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging.
Chen W; Botvinick EH; Alavi A; Zhang Y; Yang S; Perini R; Zhuang H
J Nucl Cardiol; 2008; 15(1):73-9. PubMed ID: 18242482
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and regulation of 123I-MIBG transport in cultured pulmonary endothelial cells.
Lee KH; Ko BH; Paik JY; Jung KH; Bae JS; Choi JY; Choe YS; Kim BT
J Nucl Med; 2006 Mar; 47(3):437-42. PubMed ID: 16513613
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
Narita M; Kurihara T
J Cardiol; 1998 Jun; 31(6):343-9. PubMed ID: 9666388
[TBL] [Abstract][Full Text] [Related]
15. Impact of concomitant medication use on myocardial 123I-mIBG imaging results in patients with heart failure.
Jacobson AF; White S; Travin MI; Tseng C
Nucl Med Commun; 2017 Feb; 38(2):141-148. PubMed ID: 27861299
[TBL] [Abstract][Full Text] [Related]
16. Reduced lung uptake of iodine-123 metaiodobenzylguanidine in patients with myeloperoxidase antineutrophil cytoplasmic antibodies-positive vasculitis.
Yoshiike F; Koizumi T; Urushihata K; Hanaoka M; Kubo K
Respiration; 2006; 73(2):191-6. PubMed ID: 16141710
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pulmonary endothelial cell injury in the pathogenesis of pulmonary fibrosis: clinical assessment by 123I-MIBG lung scintigraphy.
Takabatake N; Arao T; Sata M; Abe S; Inoue S; Shibata Y; Takeishi Y; Kubota I
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):221-8. PubMed ID: 15449048
[TBL] [Abstract][Full Text] [Related]
18. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study.
Jacobson AF; Senior R; Cerqueira MD; Wong ND; Thomas GS; Lopez VA; Agostini D; Weiland F; Chandna H; Narula J;
J Am Coll Cardiol; 2010 May; 55(20):2212-21. PubMed ID: 20188504
[TBL] [Abstract][Full Text] [Related]
19. Use of metaiodobenzylguanidine (MIBG) in pneumology.
Giordano A; Calcagni ML; Rossi B; Rufini V; Fuso L; Valente S; Pistelli R; Franceschini R; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):49-54. PubMed ID: 9002749
[TBL] [Abstract][Full Text] [Related]
20. ACE inhibition reduces cardiac iodine-123-MIBG release in heart failure.
Takeishi Y; Atsumi H; Fujiwara S; Takahashi K; Tomoike H
J Nucl Med; 1997 Jul; 38(7):1085-9. PubMed ID: 9225795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
